<DOC>
	<DOCNO>NCT01130363</DOCNO>
	<brief_summary>The class proton pump inhibitor ( PPI ) medication omeprazole proven extremely effective treatment prevention gastric duodenal ulcer . Although FDA approval PPI therapy limit 6-8 week , many individual remain agent year , human study suggest long-term use PPI result enterochromaffin-like ( ECL ) cell hyperplasia , well associate development fundic-gland polyp stomach . These finding raise concern possibility long-term use PPIs may predispose development neuroendocrine tumor patient . The investigator aim examine clinical parameter , include history PPI use fast gastrin level , well histologic characteristic ( particularly presence ECL-cell hyperplasia ) patient find fundic gland polyp endoscopy . The investigator hypothesize correlation fundic gland polyp stomach use proton pump inhibiter medication .</brief_summary>
	<brief_title>Fundic Gland Polyps Proton Pump Inhibitor ( PPI ) Drugs</brief_title>
	<detailed_description />
	<mesh_term>Polyps</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Adenomatous Polyps</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>Age 18 . Able willing sign inform consent . The patient gastric fundic gland polyp detect EGD remove sent pathology patient fundic gland polyp EGD PPIs serve control . Unwilling unable sign inform consent study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Proton Pump Inhibitor</keyword>
	<keyword>Gastric carcinoid tumor</keyword>
	<keyword>Gastric cancer</keyword>
	<keyword>Fundic Gland Polyps</keyword>
</DOC>